Biote is a company based in the United States that operates within the manufacturing sector, specifically focusing on health and nutrition products. Established in 2012, Biote employs between 201 and 500 individuals and reported a revenue of approximately $195.6 million. The company’s expertise is reflected in its published research, such as the document titled "The Cardiovascular Benefits of Testosterone Treatment," which explores the role of testosterone in cardiovascular health. This comprehensive review highlights the implications of testosterone deficiency and its association with cardiovascular disease, noting that testosterone plays a significant role in various physiological processes beyond its effects on sexuality. The document discusses established cardiovascular risk factors and suggests that testosterone therapy may have beneficial effects on blood pressure, lipid profiles, and atherosclerosis progression. Biote's focus on research in this area underscores its commitment to understanding the clinical implications of hormone therapy, particularly in the context of cardiovascular disease management.